EVFM · Evofem Biosciences, Inc.
$0.01
+0.00 (+7.04%)
At close · Aug 18
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has concluded that these circumstances and the uncertainties associated with the Company's ability to obtain additional equity or debt financing on terms that are favorable to the Company, or at all, and otherwise succeed in its future operations raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$940,963
Shares
132.53M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-07-02 | New | Biotechnology | $925,000 | $925,000 | 06b |
| 2025-04-15 | New | Biotechnology | $1,500,000 | $750,000 | 06b |
| 2024-08-21 | New | Biotechnology | $500,000 | $500,000 | 06b |
| 2024-08-21 | New | Biotechnology | $500,000 | $500,000 | 06b |
| 2023-10-11 | New | Biotechnology | $2,884,615 | $2,884,615 | 06b |
| 2023-03-06 | New | Biotechnology | $1,384,616 | $1,384,616 | 06b |
| 2023-02-03 | New | Biotechnology | $2,307,693 | $2,307,693 | 06b |
| 2020-10-16 | New | Biotechnology | $25,000,000 | $25,000,000 | 06b |
| 2020-05-06 | New | Biotechnology | $25,000,000 | $15,000,000 | 06b |
Showing 1–9 of 9 filings